Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Yeager, AM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 76 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Goh, M; Chen, F; Paulsen, MT; Yeager, AM; Dyer, ES; Ljungman, M
      Phenylbutyrate attenuates the expression of Bcl-X-L, DNA-PK, caveolin-1, and VEGF in prostate cancer cells

      NEOPLASIA
    2. Lonial, S; Jones, TW; Devine, S; Winton, EF; Heffner, LT; Smith, KJ; Yeager, AM; Waller, EK
      High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma

      LEUKEMIA & LYMPHOMA
    3. Zhou, M; Gu, L; Holden, J; Yeager, AM; Findley, HW
      CD40 ligand upregulates expression of the IL-3 receptor and stimulates proliferation of B-lineage acute lymphoblastic leukemia cells in the presence of IL-3

      LEUKEMIA
    4. Boyer, MW; Waller, EK; Bray, RA; Unangst, T; Johnson, TS; Phillips, C; Jurickova, I; Winton, EF; Yeager, AM
      Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells

      LEUKEMIA
    5. Zhou, M; Gu, L; Abshire, TC; Homans, A; Billett, AL; Yeager, AM; Findley, HW
      Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia

      LEUKEMIA
    6. Yeager, AM; Uhas, KA; Coles, CD; Davis, PC; Krause, WL; Moser, HW
      Bone marrow transplantation for infantile ceramidase deficiency (Farber disease)

      BONE MARROW TRANSPLANTATION
    7. Nash, RA; Antin, JH; Karanes, C; Fay, JW; Avalos, BR; Yeager, AM; Przepiorka, D; Davies, S; Petersen, FB; Bartels, P; Buell, D; Fitzsimmons, W; Anasetti, C; Storb, R; Ratanatharathorn, V
      Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

      BLOOD
    8. Walters, MC; Storb, R; Patience, M; Leisenring, W; Taylor, T; Sanders, JE; Buchanan, GE; Rogers, ZR; Dinndorf, P; Davies, SC; Roberts, IAG; Dickerhoff, R; Yeager, AM; Hsu, L; Kurtzberg, J; Ohene-Frempong, K; Bunin, N; Bernaudin, F; Wong, WY; Scott, JP; Margolis, D; Vichinsky, E; Wall, DA; Wayne, AS; Pegelow, C; Redding-Lallinger, R; Wiley, J; Klemperer, M; Mentzer, WC; Smith, FO; Sullivan, KM
      Impact of bone marrow transplantation for symptomatic sickle cell disease:an interim report

      BLOOD
    9. Parsons, SK; Gelber, S; Cole, BF; Ravindranath, Y; Ogden, A; Yeager, AM; Chang, M; Shuster, J; Weinstein, HJ; Gelber, RD
      Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group study 8821

      JOURNAL OF CLINICAL ONCOLOGY
    10. ZEDER K; WALLER EK; REDEI I; CONNAGHAN DG; FLEMING WH; GELLER RB; HEFFNER LT; HILLYER CD; HOLDEN J; HOLLAND K; JONES W; MCCOLLUM J; MOGUL M; PHILLIPS C; RODEY G; WINGARD JR; WINTON E; YEAGER AM; DEVINE S
      IMPACT OF DONOR LYMPHOCYTE INFUSION FOR HEMATOLOGICAL MALIGNANCY RELAPSED AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Cancer research, therapy & control
    11. BOAYUE KB; GU L; YEAGER AM; KREITMAN RJ; FINDLEY HW
      PEDIATRIC ACUTE MYELOGENOUS LEUKEMIA-CELLS EXPRESS IL-6 RECEPTORS ANDARE SENSITIVE TO A RECOMBINANT IL6-PSEUDOMONAS EXOTOXIN

      Leukemia
    12. ZHOU M; GU L; YEAGER AM; FINDLEY HW
      SENSITIVITY TO FAS-MEDIATED APOPTOSIS IN PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA IS ASSOCIATED WITH A MUTANT P53 PHENOTYPE AND ABSENCE OF BCL-2 EXPRESSION

      Leukemia
    13. TURNER CW; ARCHER DR; WONG J; YEAGER AM; FLEMING WH
      IN-UTERO TRANSPLANTATION OF HUMAN FETAL HEMATOPOIETIC-CELLS IN NOD SCID MICE/

      British Journal of Haematology
    14. BOMBERGER C; SINGHJAIRAM M; RODEY G; GUERRIERO A; YEAGER AM; FLEMING WH; HOLLAND HK; WALLER EK
      LYMPHOID RECONSTITUTION AFTER AUTOLOGOUS PBSC TRANSPLANTATION WITH FACS-SORTED CD34(+) HEMATOPOIETIC PROGENITORS

      Blood
    15. MOGUL MJ; FORTE KJ; HOLLAND HK; TURNER CW; BENYUNES MC; YEAGER AM
      STEROID-REFRACTORY CUTANEOUS GRAFT-VERSUS-HOST DISEASE AFTER TRANSPLANTATION OF HAPLOIDENTICAL PARENTAL CD34(-SYNDROME AND RECURRENT ACUTE-LEUKEMIA() CELLS IN CHILDREN WITH DOWNS)

      Journal of pediatric hematology/oncology
    16. ZHOU MX; GU LB; YEAGER AM; FINDLEY HW
      INCIDENCE AND CLINICAL-SIGNIFICANCE OF CDKN2 MTS1/P16(INK4A) AND MTS2/P15(INK4B) GENE DELETIONS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA/

      Pediatric hematology and oncology
    17. GU L; ZHOU M; JURICKOVA I; YEAGER AM; KREITMAN RJ; PHILLIPS CN; FINDLEY HW
      EXPRESSION OF INTERLEUKIN-6 RECEPTORS BY PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS WITH THE T(4-11) TRANSLOCATION - A POSSIBLE TARGET FOR THERAPY WITH RECOMBINANT IL6-PSEUDOMONAS EXOTOXIN

      Leukemia
    18. ARCHER DR; TURNER CW; TURNER PL; HESTER LE; YEAGER AM; FLEMING WH
      COMPETITIVE ENGRAFTMENT OF ADULT AND FETAL MURINE HEMATOPOIETIC PROGENITOR CELLS FOLLOWING IN-UTERO TRANSPLANTATION

      Experimental hematology
    19. YEAGER AM; OSOWSKI C; MULLINS R; KAPLAN C; BOYER M; DEVINE S; FORTE K; LAUER M; MOGUL M; OLSON E; OLSON T; TURNER C; VEGA R
      DAILY BUSULFAN PLUS MELPHALAN AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HIGH-RISK SOLID TUMORS - PHARMACOKINETIC STUDIES AND CLINICAL-RESULTS

      Experimental hematology
    20. WALLER EK; WORFORD LJ; LYNN M; WINTON EF; BRAY RA; JONES W; ROSENTHAL H; MCCOLLUM J; HOLLAND HK; YEAGER AM
      PLATELET RECOVERY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION CORRELATES WITH THE CONTENT OF CD34-CELLS IN THE MARROW GRAFT(, CD38)

      Experimental hematology
    21. HOLLAND HK; BRAY RA; OTOOLE K; HOLDEN JT; CONNAGHAN DG; HEFFNER LT; WALLER EK; WINTON EF; YEAGER AM
      PRESENCE OF MINIMAL RESIDUAL DISEASE (MRD) IN ACUTE MYELOGENOUS LEUKEMIA (AML) PATIENTS PREALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IS ASSOCIATED WITH A LOWER RELAPSE-FREE SURVIVAL (RFS)

      Experimental hematology
    22. ARCHER DR; TURNER CW; YEAGER AM; FLEMING WH
      SUSTAINED MULTILINEAGE ENGRAFTMENT OF ALLOGENEIC HEMATOPOIETIC STENT CELLS IN NOD SCID MICE AFTER IN-UTERO TRANSPLANTATION/

      Blood
    23. BOYER MW; JURICKOVA I; UNANGST T; HANDOYO S; GU L; YEAGER AM; ZHOU M; FINDLEY HW
      BCL-2 CAN MEDIATE RESISTANCE TO LAK BUT NOT CTL EFFECTORS IN HUMAN PRE-B ALL

      Blood
    24. ZHOU M; GU L; YEAGER AM; FINDLEY HW
      EXPRESSION OF BCL-2 IS ASSOCIATED WITH INHIBITION OF FAS-INDUCED CPP32 ACTIVATION AND APOPTOSIS IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS

      Blood
    25. DAVIES SM; HARRIS RE; VANWEELSIPMAN MH; DOKAL I; SKINNER R; CASPER JT; KURTZBERG J; SMITH F; KARANES C; CHEN A; CAIRO M; YEAGER AM; DEFOR T; WAGNER JE
      UNRELATED DONOR STEM-CELL TRANSPLANT FOR FANCONI-ANEMIA - MULTICENTERREPORT OF 49 CASES

      Blood
    26. ZHOU M; GU L; JURICKOVA I; YARRINGTON AK; ABSBIRE T; HOMANS A; YEAGER AM; FINDLEY HW
      ELEVATED MDM2 PROTEIN EXPRESSION IN PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IS ASSOCIATED WITH IN-VITRO RESISTANCE TO ADRIAMYCIN AND DECREASED DURATION OF FIRST REMISSION (CR-1)

      Blood
    27. YEAGER AM; AMYLON M; WAGNER J; CALDERWOOD S; ANASETTI C; SENDER L; JACOBS C; BENYUNES M
      ALLOGENEIC STEM-CELL TRANSPLANTATION FROM HLA-HAPLOIDENTICAL RELATIVES AS TREATMENT FOR CHILDREN WITH HEMATOLOGIC MALIGNANCY - A PHASE I IISTUDY USING MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) THAT HAVE UNDERGONE CD34 SELECTION FOLLOWED BY CD2 DEPLETION/

      Blood
    28. WALLER EK; LYNN M; WORFORD L; WINTON EF; REDEI I; HEFFNER T; HILLYER CD; SMITH K; BUCUR S; LOPEZ R; BRAY RA; JONES W; ROSENTHAL H; MCCOLLUM J; YEAGER AM
      THE NUMBER OF CD34- CELLS IN THE GRAFT PREDICTS THE KINETICS OF HEMATOPOIETIC RECONSTITUTION FOLLOWING AUTOLOGOUS OR ALLOGENEIC BONE-MARROWTRANSPLANTATION (BMT)(, CD38)

      Blood
    29. WALLER EK; REDEI I; YEAGER AM; WINTON EF; HEFFNER T; HILLYER CD; CARTER R; SMITH K; HOLLAND HK; CONNAGHAN G; PHILLIPS C; HOLDEN JT; GUERRIERO A; MURRAY T; WORFORD L; JURICKOVA I; BOYER M
      7.5 GY IRRADIATION ATTENUATES THE GRAFT-VS-HOST DISEASE (GVHD) POTENTIAL OF ALLOGENEIC LYMPHOCYTES WHILE PRESERVING ANTILEUKEMIC ACTIVITY IN PRECLINICAL AND CLINICAL-STUDIES

      Blood
    30. NASH RA; ANTIN J; KARANES C; FAY J; AVALOS B; YEAGER AM; PRZEPIORKA D; DAVIES S; PETERSEN F; BUELL D; FITZSIMMONS W; BARTELS P; HANSEN J; ANASETTI C; STORB R; RATANATHARATHORN V
      PHASE-III STUDY COMPARING TACROLIMUS (FK506) WITH CYCLOSPORINE (CSP) FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROWTRANSPLANTATION FROM UNRELATED DONORS

      Blood
    31. FINDLEY HW; GU LB; YEAGER AM; ZHOU MX
      EXPRESSION AND REGULATION OF BCL-2, BCL-XL, AND BAX CORRELATE WITH P53 STATUS AND SENSITIVITY TO APOPTOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA

      Blood
    32. BOMBERGER C; RODEY G; GUERRIERO A; JAIRAM M; YEAGER AM; FLEMING WH; HOLLAND HK; WALLER EK
      LYMPHOID RECONSTITUTION FOLLOWING AUTOLOGOUS PBSC TRANSPLANTATION WITH FACS SORTED CD34+ HEMATOPOIETIC PROGENITORS

      Experimental hematology
    33. ZHOU M; GU L; YEAGER AM; FINDLEY HW
      EXPRESSION AND REGULATION OF BCL-2 AND BCL-XL CORRELATE WITH P53 STATUS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA

      Experimental hematology
    34. HOLLAND HK; FLEMING WH; WALLER EK; GELLER RB; CONNAGHAN DG; DEVINE SD; YEAGER AM
      SELECTION AND TRANSPLANTATION OF AUTOLOGOUS CD34-BLOOD STEM-CELLS IN NON-HODGKINS-LYMPHOMA USING HIGH-SPEED FLUORESCENCE-ACTIVATED CELL SORTING( PERIPHERAL)

      Experimental hematology
    35. RAVINDRANATH Y; YEAGER AM; CHANG MN; STEUBER CP; KRISCHER J; GRAHAMPOLE J; CARROLL A; INOUE S; CAMITTA B; WEINSTEIN HJ
      AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS INTENSIVE CONSOLIDATIONCHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA IN CHILDHOOD

      The New England journal of medicine
    36. WALLACE DC; FLEMING WH; KRAWIECKI N; YEAGER AM; SHOFFNER JM
      GRANULOCYTE-COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN THERAPY IN PEARSONS SYNDROME

      Neurology
    37. TURNER CW; YEAGER AM; FLEMING WH
      INTRACELLULAR CYTOKINE PRODUCTION BY XENOGRAFTED HUMAN T-CELLS

      Blood
    38. REDEI I; GELLER RB; OTOOLE K; DEVINE S; HOLLAND HK; WINGARD JR; YEAGER AM
      FEASIBILITY OF 2ND MYELOABLATIVE THERAPY FOLLOWED BY MATCHED UNRELATED DONOR (MUD) TRANSPLANT FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES WHO RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)

      Blood
    39. YEAGER AM; ANASETTI C; CHAUNCEY T; DIPERSIO JF; HOLLAND HK; LEMAISTRE CF; RYBKA W; JACOBS CA; BENYUNES MC
      TRANSPLANTATION OF POSITIVELY SELECTED CD34-MARROW AND MOBILIZED PERIPHERAL-BLOOD CELLS FROM HAPLOIDENTICAL RELATED DONORS FOR HIGH-RISK HEMATOLOGIC MALIGNANCIES( BONE)

      Blood
    40. BOYER MW; JOHNSON TS; WALLER EK; YEAGER AM
      CYTOKINE UP-REGULATION OF ACUTE MYELOID-LEUKEMIA COSTIMULATORY FUNCTION

      Blood
    41. FINDLEY HW; GU L; YEAGER AM; ZHOU M
      EXPRESSION AND REGULATION OF BCL-2, BCL-XL, AND BAX CORRELATE WITH P53 STATUS AND SENSITIVITY TO APOPTOSIS CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA

      Blood
    42. BOYER MW; JOHNSON TS; YEAGER AM; WALLER EK
      ALLOGENEIC CYTOTOXIC T-LYMPHOCYTES CAN MEDIATE GRAFT-VERSUS-LEUKEMIA WITHOUT CAUSING GRAFT-VERSUS-HOST DISEASE

      Blood
    43. TURNER CW; FINDLEY HW; YEAGER AM; FLEMING WH
      ALLOGENEIC PERIPHERAL-BLOOD MONONUCLEAR-CELLS INHIBIT THE GROWTH OF HUMAN ACUTE LYMPHOCYTIC-LEUKEMIA IN BNX MICE

      Blood
    44. ZHOU M; GU L; YEAGER AM; FINDLEY HW
      EFFECTS OF ENDOGENOUS TNF-ALPHA ON ACTIVATION OF NF-KAPPA-B AND GROWTH OF PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS

      Blood
    45. LIN L; HOLDEN JT; JONES TW; HOLLAND HK; YEAGER AM; WALLER EK
      ETHNIC AND RACIAL-DIFFERENCES INFLUENCE CELL YIELDS FROM BONE-MARROW COLLECTIONS

      Blood
    46. HOLLAND HK; FLEMING WH; WALLER EK; CONNAGHAN DG; GELLER RB; WINGARD JR; YEAGER AM
      SELECTION AND TRANSPLANTATION OF AUTOLOGOUS CD34-BLOOD STEM-CELLS IN NON-HODGKINS-LYMPHOMA USING HIGH-SPEED FLUORESCENCE-ACTIVATED CELL SORTING( PERIPHERAL)

      Blood
    47. FLEMING WH; TURNER CW; TURNER PL; YEAGER AM; ARCHER DR
      HIGH-LEVELS OF ENGRAFTMENT OF ALLOGENEIC HEMATOPOIETIC STEM-CELLS FOLLOWING IN-UTERO TRANSPLANTATION

      Blood
    48. TURNER CW; YEAGER AM; WALLER EK; WINGARD JR; FLEMING WH
      ENGRAFTMENT POTENTIAL OF DIFFERENT SOURCES OF HUMAN HEMATOPOIETIC PROGENITOR CELLS IN BNX MICE

      Blood
    49. YEAGER AM
      THE PEDIATRICIAN AND CANCER PREVENTION - ACCEPTING THE PRESENT, CHANGING THE FUTURE

      Archives of pediatrics & adolescent medicine
    50. YEAGER AM
      THE PEDIATRICIAN AND CANCER PREVENTION - REPLY

      Archives of pediatrics & adolescent medicine
    51. ZHOU M; GU L; JAMES CD; HE J; YEAGER AM; SMITH SD; FINDLEY HW
      HOMOZYGOUS DELETIONS OF THE CDKN2 (MTS1 P16(INK4)) GENE IN CELL-LINESESTABLISHED FROM CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA/

      Leukemia
    52. FLEMING WH; WALLER EK; YEAGER AM; WINGARD JR; TURNER CW
      DEVELOPMENTAL POTENTIAL OF DIFFERENT SOURCES OF HUMAN HEMATOPOIETIC STEM-CELLS

      Experimental hematology
    53. HOLLAND HK; YEAGER AM; GELLER RB; WINGARD JR; MCCOLLUM J; FORTE KJ; MOGUL MJ; JACOBS CA; BERENSON RJ
      ENRICHMENT OF CD34-CELL PRODUCTS OBTAINED FROM HAPLOIDENTICAL NORMAL DONORS BY APHERESIS OF G-CSF MOBILIZED PERIPHERAL-BLOOD CELLS AND COLLECTION OF BONE-MARROW( CELLS AND DEPLETION OF CD3+ CELLS FROM HEMATOPOIETIC STEM)

      Experimental hematology
    54. RATANAPRASATPORN S; CANNON D; ARCHER DR; YEAGER AM
      MULTIPLE CONGENIC BONE-MARROW TRANSPLANTS WITHOUT MYELOABLATION DO NOT PROLONG SURVIVAL IN DEMYELINATING MURINE LYSOSOMAL STORAGE DISEASE (THE TWITCHER MOUSE)

      Experimental hematology
    55. MOGUL MJ; FORTE KJ; TURNER CW; VEGA RA; HOLLAND HK; WINGARD JR; JACOBS CA; BENYUNES MC; BERENSON R; YEAGER AM
      STEROID-REFRACTORY CUTANEOUS GRAFT-VERSUS-HOST DISEASE AFTER TRANSPLANTATION OF HAPLOIDENTICAL PARENTAL CD34-SYNDROME AND RELAPSED ACUTE-LEUKEMIA( CELLS IN CHILDREN WITH DOWNS)

      Experimental hematology
    56. YEAGER AM; HOLLAND HK; WINGARD JR; FORTE KJ; MOGUL MJ; TURNER CW; VEGA RA; BEATTY PG; JACOBS CA; BENYUNES MC; BERENSON R
      TRANSPLANTATION OF HAPLOIDENTICAL POSITIVELY-SELECTED CD34-LEUKEMIA IN CHILDREN( CELLS FROM PARENTAL DONORS FOR RELAPSED ACUTE)

      Experimental hematology
    57. TURNER CW; YEAGER AM; PHARR J; WINGARD JR; WALLER EK; FLEMING WH
      HIGH-MOLECULAR-WEIGHT DEXTRAN SEDIMENTATION ENHANCES RECOVERY OF HEMATOPOIETIC PROGENITORS FROM UMBILICAL-CORD BLOOD

      Experimental hematology
    58. GU L; BOAYUE KB; ZHOU M; YEAGER AM; FINDLEY HW
      EXPRESSION OF INTERLEUKIN-6 RECEPTORS BY PEDIATRIC ACUTE MYELOID-LEUKEMIA (AML) AND MYELOID-ANTIGEN-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (MY- A POTENTIAL TARGET FOR THERAPY(ALL) CELLS )

      Blood
    59. FLEMING WH; TURNER CW; WALLER EK; YEAGER AM
      CONSISTENT HIGH-FREQUENCY ENGRAFTMENT OF HUMAN-LYMPHOCYTES IN BNX MICE

      Blood
    60. FINDLEY HW; GU L; WU J; YEAGER AM; ZHOU M
      EXPRESSION OF FAS AND BCL-2 BY CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIACELLS - INVOLVEMENT OF BCL-2 IN FAS-MEDIATED APOPTOSIS

      Blood
    61. YEAGER AM; HOLLAND HK; MOGUL MJ; FORTE K; LAUER M; BOYER MW; TURNER CW; VEGA RA; BEATTY PG; JACOBS CA; BENYUNES MC; WINGARD JR
      TRANSPLANTATION OF POSITIVELY SELECTED CD34-LEUKEMIA IN CHILDREN( CELLS FROM HAPLOIDENTICAL PARENTAL DONORS FOR RELAPSED ACUTE)

      Blood
    62. ZHOU M; GU L; YEAGER AM; FINDLEY HW
      DIFFERENTIAL REGULATION OF BCL-2 AND BAX GENE-EXPRESSION IN THE RESPONSE TO TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND IONIZING-RADIATION BY TNF- ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINES( AND TNF)

      Blood
    63. YEAGER AM; MOSER HW; FORTE KJ; GIESELMANN V; NATOWICZ M; MORRISON LA; THOMPSON MG; PALLEY T
      ALLOGENEIC BONE-MARROW TRANSPLANTATION PROVIDES BIOCHEMICAL IMPROVEMENT AND STABILIZES THE NEUROCOGNITIVE STATUS IN THE ADULT FORM OF METACHROMATIC LEUKODYSTROPHY

      Blood
    64. ZHOU MX; YEAGER AM; SMITH SD; FINDLEY HW
      OVEREXPRESSION OF THE MDM2 GENE BY CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS EXPRESSING THE WILD-TYPE P53 GENE

      Blood
    65. SHOFFNER JM; FLEMING WH; KRAWIECKI N; YEAGER AM; WALLACE DC
      GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AND ERYTHROPOIETIN (EPO) THERAPY IN PEARSONS SYNDROME (PS)

      American journal of human genetics
    66. QUIGLEY PM; YEAGER AM; LOUGHLIN GM
      THE EFFECTS OF BONE-MARROW TRANSPLANTATION ON PULMONARY-FUNCTION IN CHILDREN

      Pediatric pulmonology
    67. ZHOU M; MA L; RIZACK T; YEAGER AM; FINDLEY HW
      EXPRESSION OF INTERLEUKIN-6 AND INTERLEUKIN-6 RECEPTORS IN PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA - PATHOPHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS

      Experimental hematology
    68. ZHOU M; FINDLEY HW; SMITH SD; YEAGER AM
      ABNORMALITIES OF P53 TUMOR-SUPPRESSOR GENE AND MDM2 ONCOGENE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA

      Experimental hematology
    69. YEAGER AM; SHINN C; BO L; TRAPP B
      APPEARANCE AND DEVELOPMENT OF MURINE MICROGLIA - A QUANTITATIVE STUDY

      Pediatric research
    70. FLEMING WH; TROUNCE I; KRAWIECKI N; WINGARD JR; YEAGER AM; WALLACE DC; SCHOFFNER JM
      CYTOKINE TREATMENT IMPROVES THE HEMATOLOGIC MANIFESTATIONS OF PEARSONS SYNDROME

      Blood
    71. ZHOU M; YEAGER AM; GU L; FINDLEY HW
      IDENTIFICATION OF RB MUTATIONS AND P53 MUTATIONS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINES

      Blood
    72. MA L; GU L; YEAGER AM; FINDLEY HW
      INDUCTION OF EXPRESSION OF P21 (WAF1 CIP1) AND GADD45 GENES CORRELATES WITH SENSITIVITY TO IONIZING-RADIATION (IR) IN PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) CELLS/

      Blood
    73. ZHOU M; GU L; YEAGER AM; FINDLEY HW
      CLINICAL IMPORTANCE OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) EXPRESSION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)

      Blood
    74. YEAGER AM; VOGELSANG GB; JONES RJ; FARMER ER; HESS AD; SANTOS GW
      CYCLOSPORINE-INDUCED GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA

      Leukemia & lymphoma
    75. MAY WS; SENSENBRENNER LL; BURNS WH; AMBINDER R; CARROLL MP; GRIFFIN CA; JONES RJ; MILLER CB; MELLITS ED; VOGELSANG GB; WAGNER JE; WINGARD JR; YEAGER AM; SANTOS GW
      BMT FOR SEVERE APLASTIC-ANEMIA USING CYCLOSPORINE

      Bone marrow transplantation
    76. YEAGER AM; SHINN C; SHINOHARA M; PARDOLL DM
      HEMATOPOIETIC-CELL TRANSPLANTATION IN THE TWITCHER MOUSE - THE EFFECTS OF PRETRANSPLANT CONDITIONING WITH GRADED DOSES OF BUSULFAN

      Transplantation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/05/20 alle ore 18:22:10